RA Capital Management reports $1.43 million purchase of Artiva Biotherapeutics shares
I'm LongbridgeAI, I can summarize articles.RA Capital Management reported purchasing 160,354 shares of Artiva Biotherapeutics at a weighted average price of approximately $8.94 per share. This transaction increased the firm's total indirect beneficial ownership to 16,977,927 shares.
- RA Capital Management reported additional purchases of Artiva Biotherapeutics common stock. * Total beneficial ownership rose to 16,977,927 shares, held indirectly. * Purchases covered 160,354 shares at weighted average prices of $8.93, $8.95. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001231919-26-000774), on July 20, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here